IP Library Granted Patent US 12,527,597
Granted Patent B2
US 12,527,597 · App. 17/687,370 · Granted Jan 20, 2026

Cellulite treatment system and methods

Inventors: Jonathan Podmore (San Carlos, CA); Earl Bright, II (Sunnyvale, CA); Joshua Makower (Los Altos Hills, CA); Bryan Hartley (Redwood City, CA); John Hanley (Manhattan Beach, CA); Pablo Acosta (Newark, CA); Theodore Ketai (Chico, CA); William Sauway Law (Palo Alto, CA); Michael Schaller (Louisville, CO); Arthur Ferdinand (Gilroy, CA); Charles Okehie (Rochester, NY); Christopher Scott Jones (Menlo Park, CA); Amanda White (Mountain View, CA)
Assignee: Revelle Aesthetics, Inc.
A61B17/32093A61B17/3201A61B17/3211A61N5/0616A61B2017/00761A61B2017/32113A61N2005/063A61N2005/0651
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,527,597
App. No.
17/687,370
Granted
Jan 20, 2026
Kind
B2
Abstract

Systems and methods for treating cellulite including an apparatus that applies or a method involving separating septa to eliminate or reduce the appearance of cellulite. In one approach, an interventional tool is placed between tissue layers to engage and treat septa connecting tissue layers between which fat deposits are contained.

Claims (54)

1 . A method of treating an appearance of cellulite on skin of a patient, the method comprising:

advancing a cellulite treatment system to a target site between tissue layers connected by a septum, the cellulite treatment system having a mechanical septa disrupting element and a septa hooking element;

tracking, using transillumination, a position of the cellulite treatment system between the tissue layers;

deploying the septa hooking element to a first position in which the septa disrupting element is shielded;

engaging the septum to determine that the septum is associated with the appearance of cellulite;

transitioning the septa hooking element to a second position to expose the septa disrupting element;

separating the septum with the septa disrupting element; and

temporarily stretching the skin by placing an apparatus on the skin.

2 . The method of claim 1 , further comprising creating a treatment regimen involving treatment of multiple areas by accessing an insertion site to treat the multiple areas.

3 . The method of claim 1 , wherein engaging the septum includes tensioning the septum with the septa hooking element.

4 . The method of claim 1 , wherein advancing the cellulite treatment system is with a shaft of the cellulite treatment system sized and shaped to be inserted and advanced without assistance from a tissue stabilizing structure applied to the skin of the patient.

5 . The method of claim 1 , further comprising scanning the skin of the patient to identify multiple treatment areas and to create a treatment regimen including a scanning date for assessing an efficacy of a treatment.

6 . The method of claim 1 , further comprising removing a section of the separated septum using a tube.

7 . The method of claim 1 , further comprising combining a plurality of cellulite treatment devices into the cellulite treatment system.

8 . The method of claim 1 , further comprising confirming that the septum is separated.

9 . The method of claim 1 , further comprising:

engaging a second septum based on the appearance of cellulite persisting; and

separating the second septum.

10 . A system for treating an appearance of cellulite on skin of a patient, the system comprising:

a handle;

a first member extending distally from the handle, the first member being configured to be inserted through the skin;

a second member configured to expand relative to the first member, wherein the second member is generally longitudinally aligned with the first member in a stowed configuration and configured to engage one or more regions of septa subcutaneously when expanded, wherein the second member has a septa hooking structure and a septa severing or disrupting structure; and

a light transmitting assembly coupled to the first member and including a light source, a spherical lens, and a light fiber.

11 . The system of claim 10 , wherein the septa severing or disrupting structure comprises at least one cutting surface, is exposed.

12 . The system of claim 11 , wherein the at least one cutting surface is sharp.

13 . The system of claim 10 , wherein the septa hooking structure is configured to tug tissue to produce an expression effect of at least a portion of the cellulite expressed on a surface of skin prior to removing the appearance of the cellulite.

14 . The system of claim 10 , wherein a light emitted from the light fiber is capable of being viewed through the skin to identify a location of a treatment site.

15 . The system of claim 10 , wherein the system is configured to generate a tactile feedback signaling that the second member is in a septa severing or disrupting configuration.

16 . The system of claim 10 , wherein the light source is positioned on a proximal end of the light fiber.

17 . The system of claim 10 , wherein the septa severing or disrupting structure comprises a laterally extending scissor structure.

18 . The system of claim 10 , wherein the septa severing or disrupting structure comprises a sharpened edge on a back side of the septa hooking structure.

19 . The system of claim 10 , wherein the second member is rotatably attached to the first member and is configured to project laterally to capture the one or more regions of septa, and the septa severing or disrupting structure includes a blade sized and shaped to slide along the first member to cut the one or more regions of septa.

20 . The system of claim 10 , further comprising:

a pusher coupled to the first member,

wherein the second member includes a first link and a second link, the first link is rotatably attached at a first end to an end of the pusher and is rotatably attached at a second end to a first end of the second link, a second end of the second link is rotatably attached to the first member, and actuation of the pusher expands the first link and the second link relative to the first member to engage the one or more regions of septa.

21 . The system of claim 10 , further comprising a template sized and shaped to be placed on the skin of the patient and to facilitate identification of a treatment area below the skin.

22 . The system of claim 10 , wherein the second member comprises a first link including the septa severing or disrupting structure and a second link comprising a blocker, the first link and the second link are configured to project from the first member to engage the one or more regions of septa, and the second link is curved or angled to occupy a space between the first link and the first member when the first link projects from the first member.

23 . The system of claim 10 , wherein the light transmitting assembly further comprises a ferrule about the light fiber, wherein the ferrule includes a chamfer for directing light to the light fiber.

24 . The system of claim 10 , wherein the light source is an LED.

25 . The system of claim 10 , wherein the light transmitting assembly further comprises a collimating lens configured to focus light energy from the light source.

26 . The system of claim 10 , further comprising an elongate sheath extending within the first member, wherein the elongate sheath is sized and shaped to receive the light fiber.

27 . The system of claim 26 , wherein the first member has a hole, and the light fiber projects light through the hole.

28 . The system of claim 10 , further comprising a retractable knife extendable from a distal portion of the first member.

29 . The system of claim 10 , wherein the first member has a distal portion that is rounded or tapered.

30 . The system of claim 29 , the distal portion comprises a nosecone.

31 . A method for treating an appearance of cellulite on skin of a patient, the method comprising:

advancing a cellulite treatment system along a superficial path to a target site between tissue layers connected by a septum, the cellulite treatment system having a mechanical septa disrupting element and a septa hooking element;

deploying the septa hooking element to a first position in which the septa disrupting element is shielded;

engaging the septum and pulling the septum a distance of about 10 to 20 mm to determine that the septum is associated with the appearance of cellulite;

transitioning the septa hooking element to a second position to expose the septa disrupting element; and

separating the septum.

32 . The method of claim 31 , further comprising:

engaging and pulling a second septum with the cellulite treatment system to determine that the second septum is associated with the appearance of cellulite; and

separating the second septum.

Assignments (1)
SECURITY INTEREST Recorded May 31, 2023
From: REVELLE AESTHETICS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 063803/0159 →
Continuity (5)
Continuation PCTUS2020049590 · Sep 5, 2020
Provisional Application 63049705 · Jul 9, 2020
Provisional Application 62911111 · Oct 4, 2019
Provisional Application 62896676 · Sep 6, 2019
Related Publication 20220183714A1 · Jun 16, 2022
References Cited (128)
US 4444185A · Shugar · 1984 [cited by applicant]
US 5113476A · Okada et al. · 1992 [cited by applicant]
US 5478347A · Aranyi · 1995 [cited by applicant]
US 5649947A · Auerbach et al. · 1997 [cited by applicant]
US 5728112A · Yoon · 1998 [cited by applicant]
US 5749147A · Hasegawa · 1998 [cited by applicant]
US 6165188A · Saadat et al. · 2000 [cited by applicant]
US 6377854B1 · Knowlton · 2002 [cited by applicant]
US 6447527B1 · Thompson et al. · 2002 [cited by applicant]
US 7179272B2 · Kieturakis et al. · 2007 [cited by applicant]
US 7217265B2 · Hennings et al. · 2007 [cited by applicant]
US 7442192B2 · Knowlton · 2008 [cited by applicant]
US 7671423B2 · Voldman · 2010 [cited by applicant]
US 7771374B2 · Slatkine · 2010 [cited by applicant]
US 7871423B2 · Livneh · 2011 [cited by applicant]
US 8167280B2 · Chomas et al. · 2012 [cited by applicant]
US 8348867B2 · Deem et al. · 2013 [cited by applicant]
US 8439940B2 · Chomas et al. · 2013 [cited by applicant]
US 8652123B2 · Gurtner · 2014 [cited by applicant]
US 8979881B2 · Clark, III · 2015 [cited by applicant]
US 9358033B2 · Ballakur et al. · 2016 [cited by applicant]
US 9539439B2 · Jones et al. · 2017 [cited by applicant]
US 9550052B2 · Ignon et al. · 2017 [cited by applicant]
US 9615882B2 · Shroff et al. · 2017 [cited by applicant]
US 9919168B2 · Altshuler et al. · 2018 [cited by applicant]
US 9974519B1 · Schwarz et al. · 2018 [cited by applicant]
US 10117892B2 · Perry · 2018 [cited by applicant]
US 10271866B2 · Clark, III · 2019 [cited by applicant]
US 10549110B1 · Schwarz · 2020 [cited by applicant]
US 10603101B2 · Weber · 2020 [cited by applicant]
US 10888348B2 · Gutwein et al. · 2021 [cited by applicant]
US 11013527B1 · Podmore et al. · 2021 [cited by applicant]
US 11116888B2 · Bright, II et al. · 2021 [cited by applicant]
US 11974767B2 · Makower · 2024 [cited by examiner]
US 20010025190A1 · Weber et al. · 2001 [cited by applicant]
US 20030032950A1 · Altshuler et al. · 2003 [cited by applicant]
US 20030130628A1 · Duffy · 2003 [cited by applicant]
US 20030158566A1 · Brett · 2003 [cited by applicant]
US 20030187457A1 · Weber · 2003 [cited by applicant]
US 20040049251A1 · Knowlton · 2004 [cited by applicant]
US 20040204734A1 · Wagner et al. · 2004 [cited by applicant]
US 20040206365A1 · Knowlton · 2004 [cited by applicant]
US 20040243159A1 · Shiuey · 2004 [cited by applicant]
US 20040260210A1 · Ella et al. · 2004 [cited by applicant]
US 20050251120A1 · Anderson et al. · 2005 [cited by applicant]
US 20060036164A1 · Wilson · 2006 [cited by examiner]
US 20060074313A1 · Slayton et al. · 2006 [cited by applicant]
US 20060172255A1 · Hochman et al. · 2006 [cited by applicant]
US 20060241663A1 · Rice et al. · 2006 [cited by applicant]
US 20060241673A1 · Zadini et al. · 2006 [cited by applicant]
US 20070005091A1 · Zadini et al. · 2007 [cited by applicant]
US 20080006551A1 · Tolley et al. · 2008 [cited by applicant]
US 20080015624A1 · Sonoda et al. · 2008 [cited by applicant]
US 20080051627A1 · Raju · 2008 [cited by applicant]
US 20080058603A1 · Edelstein et al. · 2008 [cited by applicant]
US 20080109023A1 · Greer · 2008 [cited by applicant]
US 20080200863A1 · Chomas et al. · 2008 [cited by applicant]
US 20080275569A1 · Lesh · 2008 [cited by applicant]
US 20090093737A1 · Chomas et al. · 2009 [cited by applicant]
US 20090248004A1 · Altshuler et al. · 2009 [cited by applicant]
US 20090275899A1 · Deem et al. · 2009 [cited by applicant]
US 20100057056A1 · Gurtner et al. · 2010 [cited by applicant]
US 20100106063A1 · Chomas et al. · 2010 [cited by applicant]
US 20100137799A1 · Imai · 2010 [cited by applicant]
US 20100228182A1 · Clark, III · 2010 [cited by examiner]
US 20100237163A1 · Chomas et al. · 2010 [cited by applicant]
US 20100256596A1 · Chomas · 2010 [cited by applicant]
US 20100331820A1 · Prisco et al. · 2010 [cited by applicant]
US 20110028898A1 · Clark, III et al. · 2011 [cited by applicant]
US 20110295297A1 · Shirley et al. · 2011 [cited by applicant]
US 20110319839A1 · Del Vecchio · 2011 [cited by applicant]
US 20120022510A1 · Welches et al. · 2012 [cited by applicant]
US 20120150208A1 · Messmer · 2012 [cited by applicant]
US 20120165725A1 · Chomas · 2012 [cited by examiner]
US 20130123771A1 · Clark, III et al. · 2013 [cited by applicant]
US 20130190739A1 · Clark, III et al. · 2013 [cited by applicant]
US 20130190740A1 · Clark, III et al. · 2013 [cited by applicant]
US 20130197427A1 · Merchant et al. · 2013 [cited by applicant]
US 20130197515A1 · Raybin et al. · 2013 [cited by applicant]
US 20140257272A1 · Clark, III et al. · 2014 [cited by applicant]
US 20140276693A1 · Altshuler · 2014 [cited by examiner]
US 20140335072A1 · Hart · 2014 [cited by applicant]
US 20150064165A1 · Perry · 2015 [cited by examiner]
US 20150216719A1 · DeBENEDICTIS et al. · 2015 [cited by applicant]
US 20160051314A1 · Batchelor et al. · 2016 [cited by applicant]
US 20160151646A1 · Bonutti et al. · 2016 [cited by applicant]
US 20160346037A1 · Truckai et al. · 2016 [cited by applicant]
US 20170172619A1 · Kirkemo · 2017 [cited by applicant]
US 20180116905A1 · Capelli et al. · 2018 [cited by applicant]
US 20180214169A1 · Gutwein et al. · 2018 [cited by applicant]
US 20190046738A1 · Banker · 2019 [cited by applicant]
US 20200046391A1 · Capelli et al. · 2020 [cited by applicant]
US 20200187971A1 · Clark, III et al. · 2020 [cited by applicant]
US 20200305918A1 · Fogg et al. · 2020 [cited by applicant]
US 20210093898A1 · Pooth et al. · 2021 [cited by applicant]
US 20210137551A1 · Makower et al. · 2021 [cited by applicant]
US 20210138127A1 · Makower et al. · 2021 [cited by applicant]
US 20220233259A1 · Thompson et al. · 2022 [cited by applicant]
US 20220347496A1 · Podmore et al. · 2022 [cited by applicant]
US 20220354565A1 · Podmore et al. · 2022 [cited by applicant]
US 20230255678A1 · Podmore et al. · 2023 [cited by applicant]
CN 2504047Y · 2002 [cited by applicant]
CN 201617909 · 2010 [cited by applicant]
CN 202154724 · 2012 [cited by applicant]
CN 202821527 · 2013 [cited by applicant]
CN 103313663A · 2013 [cited by applicant]
CN 204191319 · 2015 [cited by applicant]
CN 104644244 · 2015 [cited by applicant]
CN 204500879 · 2015 [cited by applicant]
EP 2504047 · 2012 [cited by applicant]
GB 2350080A · 2000 [cited by applicant]
JP H11218652A · 1999 [cited by applicant]
JP 020409B2 · 2000 [cited by applicant]
JP 2013526967A · 2013 [cited by applicant]
JP 2018010292A · 2018 [cited by applicant]
WO 1991002493A1 · 1991 [cited by applicant]
WO 2016040820A1 · 2016 [cited by applicant]
WO 2017176800A1 · 2017 [cited by applicant]
WO 2017192394A1 · 2017 [cited by applicant]
WO WO2019060924 · 2019 [cited by applicant]
WO 2019164836A1 · 2019 [cited by applicant]
WO 2020023412A1 · 2020 [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/042865, dated Nov. 14, 2019, 7 Pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2019/042871, dated Oct. 31, 2019, 6 Pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2020/049590, dated Dec. 10, 2020, 6 Pages. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2024/025149, dated Oct. 8, 2024, 12 Pages. [cited by applicant]
Extended European Search Report issued in EP Application No. 19841959.0 dated Mar. 23, 2022. [cited by applicant]
Extended European Search Report issued in EP Application No. 20861414.9 dated Sep. 1, 2023. [cited by applicant]